Pegylated Liposomal Doxorubicin and Carboplatin as First Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT01051362 · UNKNOWN
Trial details
- NCT number
- NCT01051362
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2011-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.